Author Topic: Advancing Novel Experimental Gene-based COVID-19 Vaccine, AAVCOVID  (Read 229 times)

KeithM

  • Newbie
  • *
  • Posts: 4
    • View Profile
https://eye.hms.harvard.edu/news/harvard-ophthalmology-advancing-novel-experimental-gene-based-covid-19-vaccine-aavcovid

Massachusetts Eye and Ear and Massachusetts General Hospital (MGH)—affiliates of Harvard Ophthalmology and members of Mass General Brigham—today announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19

frenchie

  • Newbie
  • *
  • Posts: 14
    • View Profile
Re: Advancing Novel Experimental Gene-based COVID-19 Vaccine, AAVCOVID
« Reply #1 on: May 05, 2020, 05:26:49 PM »
https://eye.hms.harvard.edu/news/harvard-ophthalmology-advancing-novel-experimental-gene-based-covid-19-vaccine-aavcovid

Massachusetts Eye and Ear and Massachusetts General Hospital (MGH)—affiliates of Harvard Ophthalmology and members of Mass General Brigham—today announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19

Heres the full press release. Pretty interesting read

https://www.masseyeandear.org/news/press-releases/2020/05/mee-and-mgh-advancing-aavcovid-vaccine